Literature DB >> 8839286

Biliary proliferation and adaptation in furan-induced rat liver injury and carcinogenesis.

A E Sirica1.   

Abstract

Distinctive intrahepatic biliary adaptation responses occur in the liver of rats subjected to select hepatotoxic and/or carcinogenic treatments with the nongenotoxic cholangiocarcinogenic agent furan. Specifically, metaplastic small intestinal-like glands closely resembling in their cellular composition the crypts of Lieberkühn of normal rat small intestine were selectively derived from putative hyperplastic bile ductule-like progenitor structures in the right and caudate liver lobes of young adult Fischer-344 male rats given furan by gavage at a daily dose of 30-45 mg/kg body weight, 5 times weekly, over a 2-6-wk treatment period. Longer term chronic administration of furan at 30 mg/kg/day for 9-19 wk resulted in the preferential development of primary hepatic adenocarcinomas, which arose at 70-100% incidences from right/caudate liver lobes and which were characterized by small intestine mucosal cell differentiation. Interestingly, the neoplastic glands of these "intestinal-type" hapatic tumors demonstrated strongly positive immunochemical reactions for both hepatocyte growth factor/scatter factor and its c-met encoded receptor and were immunohistochemically positive for transforming growth factor beta 1 (TGF-beta 1) and for mannose-6-phosphate/insulin-like growth factor II receptor, implicated in the activation of latent TGF-beta 1. In contrast, a different pattern of aberrant bile ductular cell differentiation was noted to occur in the atrophied right liver lobe of moribund Fischer-344 male rats that were chronically exposed over a 10-14-day period to a severely hepatotoxic dose of furan (60 mg/kg/day). Under this latter experimental condition, rare yet distinct cholangiolar-like structures composed of biliary epithelial cells and typically a single ductular hepatocytic cell in various stages of maturation specifically formed in association with an extensive hyperplastic bile ductular reaction. Very similar cholangiolar-like structures also appeared in areas of preexisting hyperplastic bile ductule tissue at 3-5 days following the administration of a single hepatonecrogenic dose of CCl4 to rats that 4-6 wk earlier had been subjected to a bile duct ligation. In addition, a novel rat model was developed in which furan combined in a unique synergistic manner with bile duct ligation to induce the replacement of almost all of liver with well-differentiated hyperplastic bile ductules without evidence of differentiation along either metaplastic small intestine mucosal cell or ductular hepatocyte lineages. Bile ductular epithelial cell isolated from bile duct-ligated/furan-treated rats were further observed to be organized in the form of bile duct-like structures in vitro under specific conditions of primary cell culture and in vivo following their cell transplantation into the inguinal fat pads of sygeneic recipient rats. Overall, these findings serve to exemplify the remarkable plasticity that may be exhibited by certain proliferating biliary cell populations in liver in response to specific types of severe hepatic injury and/or during cholangiocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8839286     DOI: 10.1177/019262339602400113

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  14 in total

1.  Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury.

Authors:  Yan Yu; Hong Jin; Daniel Holder; Josef S Ozer; Stephanie Villarreal; Paul Shughrue; Shu Shi; David J Figueroa; Holly Clouse; Ming Su; Nagaraja Muniappa; Sean P Troth; Wendy Bailey; John Seng; Amy G Aslamkhan; Douglas Thudium; Frank D Sistare; David L Gerhold
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

2.  Liver damage using suicide genes. A model for oval cell activation.

Authors:  M Bustos; B Sangro; P Alzuguren; A G Gil; J Ruiz; N Beraza; C Qian; A Garcia-Pardo; J Prieto
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 3.  Animal models of cholangiocarcinoma.

Authors:  Emilien Loeuillard; Samantha R Fischbach; Gregory J Gores; Sumera Rizvi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-04-05       Impact factor: 5.187

4.  Characterization of a novel rat cholangiocarcinoma cell culture model-CGCCA.

Authors:  Chun-Nan Yeh; Kun-Ju Lin; Tsung-Wen Chen; Ren-Ching Wu; Lee-Cheng Tsao; Ying-Tzu Chen; Wen-Hui Weng; Miin-Fu Chen
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

Review 5.  Genetics of biliary tract cancers and emerging targeted therapies.

Authors:  Aram F Hezel; Vikram Deshpande; Andrew X Zhu
Journal:  J Clin Oncol       Date:  2010-06-14       Impact factor: 44.544

6.  Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab.

Authors:  Toru Kawamoto; Kazunori Ishige; Melanie Thomas; Yoriko Yamashita-Kashima; Sei Shu; Nobuyuki Ishikura; Shunichi Ariizumi; Masakazu Yamamoto; Kunihiko Kurosaki; Junichi Shoda
Journal:  J Gastroenterol       Date:  2014-08-12       Impact factor: 7.527

7.  Establishment of a novel orthotopic xenograft model of human gallbladder carcinoma.

Authors:  Jan-Hendrik Egberts; Bodo Schniewind; Clemens Schafmayer; Marie-Luise Kruse; Bence Sipos; Fred Fändrich; Holger Kalthoff; Jürgen Tepel
Journal:  Clin Exp Metastasis       Date:  2007-04-04       Impact factor: 5.150

8.  Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats.

Authors:  Michele Barone; Eugenio Maiorano; Roberta Ladisa; Antonia Pece; Pasquale Berloco; Mario Strazzabosco; Maria Lucia Caruso; Anna Maria Valentini; Enzo Ierardi; Alfredo Di Leo; Antonio Francavilla
Journal:  Virchows Arch       Date:  2004-04-08       Impact factor: 4.064

Review 9.  Reactive metabolites in the biotransformation of molecules containing a furan ring.

Authors:  Lisa A Peterson
Journal:  Chem Res Toxicol       Date:  2012-10-24       Impact factor: 3.739

10.  HER Receptor Family: Novel Candidate for Targeted Therapy for Gallbladder and Extrahepatic Bile Duct Cancer.

Authors:  Toru Kawamoto; Savitri Krishnamurthy; Emily Tarco; Smita Trivedi; Ignacio I Wistuba; Donghui Li; Ivan Roa; Juan C Roa; Melanie B Thomas
Journal:  Gastrointest Cancer Res       Date:  2007-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.